CataRhex 3® - Strong, Beautiful, Unique – For You

Article

CataRhex 3 ? Phaco without Limits Never before has cutting-edge technology for anterior segment surgery been as easily and reliably available, and never before has its packaging been more compact and tempting.

CataRhex 3® - Strong, Beautiful, Unique – For You

Weighing as little as 5 kg and fitting in any pilot case, CataRhex 3® can be mounted on any IV pole with a click – it is thus the epitome of portable equipment. A device that takes up so little space and is so easy to handle is becoming increasingly attractive in both outpatient and high-volume clinics. After all, CataRhex3® offers the latest phaco technology, from clear lens exchange to the hardest lenses. CataRhex 3 easyPhaco® Technology is available for 1.6, 2.2 and 2.8mm incisions with unparalleled efficiency and chamber stability. The newly developed CortexModeTM makes I/A with capsule cleaning noticeably safer and faster. Anterior vitrectomies can be precisely controlled with the high-precision flow control and the pneumatic Twinac cutting instrument and thanks to the integrated air pressure compressor they are available at all times.

CataRhex 3® is a trend-setter: the HFDS® ab interno function provides MIGS technology which elegantly enables combined glaucoma/phaco surgery. In terms of femto LRCS, too, CataRhex 3® excels with perfect fragment aspiration.

Contact details:
Fabienne Kast, Product Manager Anterior
fabienne.kast@oertli-instruments.comwww.oertli-catarhex3.com

Recent Videos
3 experts are featured in this series.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.